InTech uses cookies to offer you the best online experience. By continuing to use our site, you agree to our Privacy Policy.

Medicine » Immunology, Allergology and Rheumatology » "Immunopathology and Immunomodulation", book edited by Krassimir Metodiev, ISBN 978-953-51-2210-4, Published: November 18, 2015 under CC BY 3.0 license. © The Author(s).

Chapter 9

Probiotics and Immunity

By Marieta Georgieva, Kaloyan Georgiev and Peter Dobromirov
DOI: 10.5772/61337

  1. Frei R, Akdis M, O'Mahony. Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence. Curr Opin Gastroenterol. 2015;31(2):153-8. DOI: 10.1097/MOG.0000000000000151.

  2. Johnson BR, Klaenhammer TR. Impact of genomics on the field of probiotic research: historical perspectives to modern paradigms. Antonie Van Leeuwenhoek. 2014;106(1):141-56. DOI: 10.1007/s10482-014-0171-y

  3. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59-65. DOI: 10.1038/nature08821

  4. Ianiro G, Bibbò S, Gasbarrini A, Cammarota G. Therapeutic modulation of gut microbiota: current clinical applications and future perspectives. Curr Drug Targets. 2014;15(8):762-70. DOI: 10.2174/1389450115666140606111402

  5. Masood MI, Qadir MI, Shirazi JH, Khan IU. Beneficial effects of lactic acid bacteria on human beings. Crit Rev Microbiol. 2011;37(1):91-8. DOI: 10.3109/1040841X.2010.536522

  6. Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36(5):305-12. DOI: 10.1016/j.tins.2013.01.005

  7. Vieira AT, Teixeira MM, Martins FS. The role of probiotics and prebiotics in inducing gut immunity. Front Immunol. 2013;4:445. DOI: 10.3389/fimmu.2013.00445.

  8. Pfeiler EA, Klaenhammer TR. Role of transporter proteins in bile tolerance of Lactobacillus acidophilus. Appl Environ Microbiol. 2009;75(18):6013-6. DOI: 10.1128/AEM.00495-09

  9. Kamada N, Chen GY, Inohara N, Núñez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol. 2013;14(7):685-90. DOI: 10.1038/ni.2608

  10. Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, Tuckova L, Cukrowska B, Lodinova-Zadnikova R, et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett. 2004;93(2-3):97-108.

  11. Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME. Probiotics and immunity. J Gastroenterol. 2009;44(1):26-46. DOI: 10.1007/s00535-008-2296-0

  12. Palmer S. Research Suggests Beneficial Bacteria May Support Immune Health [Internet]. Today’s Dietician. 2011;13(1):20. Available from: http://www.todaysdietitian.com/newarchives/011211p20.shtml [Accessed: 2015-04-14]

  13. Sommer F, Bäckhed F. The gut microbiota – masters of host development and physiology. Nat Rev Microbiol. 2013;11(4):227-38. DOI: 10.1038/nrmicro2974

  14. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol. 2008;8(6):411-20. DOI: 10.1038/nri2316

  15. Duerr CU, Hornef MW. The mammalian intestinal epithelium as integral player in the establishment and maintenance of host-microbial homeostasis. Semin Immunol. 2012;24(1):25-35. DOI: 10.1016/j.smim.2011.11.002

  16. Wells JM, Rossi O, Meijerink M, van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci U S A. 2011;108(Suppl1):4607-14. DOI: 10.1073/pnas.1000092107

  17. Ouwehand and Salminen. Meeting of the International Scientific Organization for Probiotics and Prebiotics; 2002; 1998.

  18. Lin PW1, Myers LE, Ray L, Song SC, Nasr TR, Berardinelli AJ, et al. Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic Biol Med. 2009;47(8):1205-11. DOI: 10.1016/j.freeradbiomed.2009.07.033

  19. Ruiz PA, Hoffmann M, Szcesny S, Blaut M, Haller D. Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. Immunology. 2005;115(4):441-50. DOI: 10.1111/j.1365-2567.2005.02176.x

  20. Yan F, Cao H, Cover TL, Washington MK, Shi Y, Liu L, et al. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest. 2011;121(6):2242-53. DOI: 10.1172/JCI44031

  21. Kim SW, Park KY, Kim B, Kim E, Hyun CK. Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production. Biochem Biophys Res Commun. 2013;431(2):258-63. DOI: 10.1016/j.bbrc.2012.12.121

  22. Giahi L, Aumueller E, Elmadfa I, Haslberger AG. Regulation of TLR4, p38 MAPkinase, IκB and miRNAs by inactivated strains of lactobacilli in human dendritic cells. Benef Microbes. 2012;3(2):91-8. DOI: 10.3920/BM2011.0052

  23. Wang S, Zhu H, Lu C, Kang Z, Luo Y, Feng L, et al. Fermented milk supplemented with probiotics and prebiotics can effectively alter the intestinal microbiota and immunity of host animals. J Dairy Sci. 2012;95(9):4813-22. DOI: 10.3168/jds.2012-5426

  24. Granato D, Branco GF, Cruz AG, Faria JA, Shah NP. Probiotic dairy products as functional foods. Comprehen Rev Food Sci Food Safety. 2010;9(5):455-470. DOI: 10.1111/j.1541-4337.2010.00120.x

  25. Cox AJ, Pyne DB, Saunders PU, Fricker PA. Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br J Sports Med. 2010;44(4):222-6. DOI: 10.1136/bjsm.2007.044628

  26. Gleeson M, Bishop NC, Oliveira M, McCauley T, Tauler P, Lawrence C. Effects of a Lactobacillus salivarius probiotic intervention on infection, cold symptom duration and severity, and mucosal immunity in endurance athletes. Int J Sport Nutr Exerc Metab. 2012;22(4):235-42.

  27. Ng SC, Hart AL, Kamm MA, Stagg AJ, Knight SC. Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis. 2009;15(2):300-10. DOI: 10.1002/ibd.20602

  28. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012;482(7384):179-85. DOI: 10.1038/nature10809

  29. Vujkovic-Cvijin I, Dunham RM, Iwai S, Maher MC, Albright RG, Broadhurst MJ et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med. 2013;5(193):193ra91. DOI: 10.1126/scitranslmed.3006438

  30. Gordon HA. Morphological and physiological characterization of germfree life. Ann N Y Acad Sci. 1959;78:208-20.

  31. Glaister JR. Factors affecting the lymphoid cells in the small intestinal epithelium of the mouse. Int Arch Allergy Appl Immunol. 1973;45(5):719-30.

  32. Cebra JJ, Periwal SB, Lee G, Lee F, Shroff KE. Development and maintenance of the gut-associated lymphoid tissue (GALT): the roles of enteric bacteria and viruses. Dev Immunol. 1998;6(1-2):13-8.

  33. Moreau MC, Ducluzeau R, Guy-Grand D, Muller MC. Increase in the population of duodenal immunoglobulin A plasmocytes in axenic mice associated with different living or dead bacterial strains of intestinal origin. Infect Immun. 1978;21(2):532-9.

  34. Selle K, Klaenhammer TR. Genomic and phenotypic evidence for probiotic influences of Lactobacillus gasseri on human health. FEMS Microbiol Rev. 2013;37(6):915-35. DOI: 10.1111/1574-6976.12021

  35. Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P et al. Alterations of the dominant faecal bacterial groups in patients with Crohn’s disease of the colon. Gut. 2003;52(2):237-42.

  36. Jeffery IB, O’Toole PW, Ohman L, Claesson MJ, Deane J, Quigley EM, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut. 2012;61(7):997-1006. DOI: 10.1136/gutjnl-2011-301501

  37. Bisgaard H, Li N, Bonnelykke K, Chawes BL, Skov T, Paludan-Muller G, et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol. 2011;128(3):646-52. DOI: 10.1016/j.jaci.2011.04.060

  38. Kalliomäki M, Isolauri E. Pandemic of atopic diseases – a lack of microbial exposure in early infancy? Curr Drug Targets Infect Disord. 2002;2(3):193-9.

  39. Rautava S, Kalliomäki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol. 2002;109(1):119-21.

  40. Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2007;119(1):192-8.

  41. Barker DJ. The origins of the developmental origins theory. J Intern Med. 2007;261(5):412-7.

  42. Boyle RJ, Mah LJ, Chen A, Kivivuori S, Robins-Browne RM, Tang ML. Effects of Lactobacillus GG treatment during pregnancy on the development of fetal antigen-specific immune responses. Clin Exp Allergy. 2008;38(12):1882-90. DOI: 10.1111/j.1365-2222.2008.03100.x

  43. Laitinen K, Poussa T, Isolauri E. Nutrition, allergy, mucosal immunology and intestinal microbiota group. Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr. 2009;101(11):1679-87. DOI: 10.1017/S0007114508111461

  44. Petersen ER, Claesson MH, Schmidt EG, Jensen SS, Ravn P, Olsen J, et al. Consumption of probiotics increases the effect of regulatory T cells in transfer colitis. Inflamm Bowel Dis. 2012;18(1):131-42. DOI: 10.1002/ibd.21709

  45. Blottière HM, de Vos WM, Ehrlich SD, Doré J. Human intestinal metagenomics: state of the art and future. Curr Opin Microbiol. 2013;16(3):232-9. DOI: 10.1016/j.mib.2013.06.006

  46. Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500(7464):541-6. DOI: 10.1038/nature12506

  47. Lebeer S, Vanderleyden J, De Keersmaecker SC. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol. 2010;8(3):171-84. DOI: 10.1038/nrmicro2297

  48. Bron PA, van Baarlen P, Kleerebezem M. Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol. 2011;10(1):66-78. DOI: 10.1038/nrmicro2690

  49. Klaenhammer TR, Kleerebezem M, Kopp MV, Rescigno M. The impact of probiotics and prebiotics on the immune system. Nat Rev Immunol. 2012;12(10):728-34. DOI: 10.1038/nri3312

  50. Yan F, Polk DB. Probiotics and immune health. Curr Opin Gastroenterol. 2011;27(6):496-501. DOI: 10.1097/MOG.0b013e32834baa4d

  51. Mohamadzadeh M, Pfeiler EA, Brown JB, Zadeh M, Gramarossa M, Managlia E, et al. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4623-30. DOI: 10.1073/pnas.1005066107

  52. Kamada N, Seo SU, Chen GY, Núñez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol. 2013;13(5):321-35. DOI: 10.1038/nri3430

  53. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004 ;118(2):229-41.

  54. Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, Sahoo A, et al. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A. 2010;107(5):2159-64. DOI: 10.1073/pnas.0904055107

  55. Cain AM, Karpa KD. Clinical utility of probiotics in inflammatory bowel disease. Altern Ther Health Med. 2011;17(1):72-9.

  56. Chomakov H. Bulgarian Yoghurt – unique probiotic, International Symposium on original Bulgarian yoghurt. In: Sofia:2005. p. 21 – 35.

  57. Chomakov H. Probiotics – past, present, future. Esprint, Sofia, 2007.

  58. Chomakov H, Tch Kondareva. Studies on the microflora of chicken digestive system. Bulg J Agricult Sci. 1995;1:56-62.

  59. Hosono A. Nutritive and physiological properties of lactic acid bacteria. In: Nagano: Japanese International Cooperation Agency (JICA); 1996. p. 30 – 32.

  60. Commission Regulation (EU) No. 432/2012 [Internet]. May 16, 2012. Available from: https://www.fsai.ie/uploadedfiles/consol_reg432_2012.pdf [Accessed: 2015-04-14]

  61. Alexandrov N. Prophylactic and treatment of multiple organ failure in poisoning with halogenated hydrocarbons. Symp of the Army Medical Services of Member States of Warsaw treaty, published by National Defense Ministry. 1988:17.

  62. Application for Patent No. 13557597/25.07.2012 in the U.S. Patent Office.

  63. Application No. 111161/07.03.2012 in Bulgarian Patent Office, Probiotics for dietary diary product.

  64. Alexandrov N, et al. The probiotics – base of functional nutrition and nutritive treatment in XXI century. In: International Symposium on Original Bulgarian Yoghurt; 2005; Sofia:p. 125-126.

  65. FAO/WHO, London, Canada. Guidelines for the Evaluation of Probiotics in Food [Internet]. 2002. Available from: http://www.fda.gov/ohrms/dockets/dockets/95s0316/95s-0316-rpt0282-tab-03-ref-19-joint-faowho-vol219.pdf [Accessed: 2015-04-14]

  66. Ministry of Health, Labour and Welfare. Available from: http://www.mhlw.go.jp/english/topics/foodsafety/fhc/02.html [Accessed: 2015-04-14]

  67. U.S. Department of Health and Human Services. U.S. Food and Drug Administration [Internet]. [Updated: 04/13/2015]. Available from: http://www.fda.gov/ [Accessed: 04-15-2015]

  68. Moeini H, Rahim RA, Omar AR, Shafee N, Yusoff K. Lactobacillus acidophilus as a live vehicle for oral immunization against chicken anemia virus. Appl Microbiol Biotechnol. 2011;90(1):77-88. DOI: 10.1007/s00253-010-3050-0

  69. Kajikawa A, Zhang L, Long J, Nordone S, Stoeker L, LaVoy A, et al. Construction and immunological evaluation of dual cell surface display of HIV-1 gag and Salmonella enterica serovar Typhimurium FliC in Lactobacillus acidophilus for vaccine delivery. Clin Vaccine Immunol. 2012;19(9):1374-81. DOI: 10.1128/CVI.00049-12

  70. Bercik P, Collins SM, Verdu EF. Microbes and the gut-brain axis. Neurogastroenterol Motil. 2012;24(5):405-13. DOI: 10.1111/j.1365-2982.2012.01906.x

  71. Sartor RB, Sherman PM, Mayer EA. An update on the use and investigation of probiotics in health and disease. Gut. 2913;62(5):787-96. DOI: 10.1136/gutjnl-2012-302504